Current Medicinal Chemistry


Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 33, November

Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs

Volume:16   Issue: 33
Pp: 4345-4360
G. D. Kolovou, K. K. Anagnostopoulou, P. M. Kostakou and D. P. Mikhailidis
DOI: 10.2174/092986709789712853
Published on: 01 March, 2012

Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?

Volume:16   Issue: 33
Pp: 4361-4373
R. Fanciullino and J. Ciccolini
DOI: 10.2174/092986709789712916
Published on: 01 March, 2012

Chemogenomic Strategies to Expand the Bioactive Chemical Space

Volume:16   Issue: 33
Pp: 4374-4381
E. Jacoby and A. Mozzarelli
DOI: 10.2174/092986709789712862
Published on: 01 March, 2012

Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection

Volume:16   Issue: 33
Pp: 4382-4398
D. Morin, R. Assaly, S. Paradis and A. Berdeaux
DOI: 10.2174/092986709789712871
Published on: 01 March, 2012

The Medicinal Chemistry of Peptides

Volume:16   Issue: 33
Pp: 4399-4418
J. J. Nestor Jr.
DOI: 10.2174/092986709789712907
Published on: 01 March, 2012

Protein Cysteine Modifications: (1) Medicinal Chemistry for Proteomics

Volume:16   Issue: 33
Pp: 4419-4444
N. Nagahara, T. Matsumura, R. Okamoto and Y. Kajihara
DOI: 10.2174/092986709789712880
Published on: 01 March, 2012

Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET

Volume:16   Issue: 33
Pp: 4445-4461
G. Lendvai, S. Estrada and M. Bergstrom
DOI: 10.2174/092986709789712844
Published on: 01 March, 2012

Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide

Volume:16   Issue: 33
Pp: 4462-4480
S. Bourgault, D. Vaudry, A. Dejda, N. D. Doan, H. Vaudry and A. Fournier
DOI: 10.2174/092986709789712899
Published on: 01 March, 2012

The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine

Volume:16   Issue: 33
Pp: 4481-4489
B. Malhotra, K. Gandelman, R. Sachse, N. Wood and M. C. Michel
DOI: 10.2174/092986709789712835
Published on: 01 March, 2012